Senior insider sale
EVP, GMDA at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$3.29M
6.99K shares
What this filing means
BOZIC CARMEN plans to sell 6.99K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $3.29M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/27/2026ACC: 0001959173-26-002646
Officer· EVP, GMDA
Since Oct 2019
6.99K
Shares to sell
$3.29M
Approx. market value
2.33K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
2/26/2025
642.00Restricted Stock Vesting
Compensation
2/24/2025
1.69KTotal acquired2.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/26/2025 | Restricted Stock Vesting Compensation | 642.00 | — |
2/24/2025 | Restricted Stock Vesting Compensation | 1.69K | — |
| Total | 2.33K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.33K
Market value
$1.12M
3/13/2026
—Completed
Units to sell
2.33K
Market value
$1.12M
2/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.33K
Market value
$1.05M
3/27/2026
Total
Units
6.99K
Value
$3.29M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/13/2026 | 2.33K | $1.12M | — | Completed |
2/27/2026 | 2.33K | $1.12M | — | Completed |
| Planned — Approximate Date | ||||
3/27/2026 | 2.33K | $1.05M | NASDAQ | Planned |
| Total | 6.99K | $3.29M | ||